Spike Antibody Levels of Nursing Home Residents With or Without Prior COVID-19 3 Weeks After a Single BNT162b2 Vaccine Dose

Hubert Blain; Edouard Tuaillon; Lucie Gamon; Amandine Pisoni; Stephanie Miot; Marie-Christine Picot; Jean Bousquet

doi:10.1001/jama.2021.6042

Spike Antibody Levels of Nursing Home Residents With or Without Prior COVID-19 3 Weeks After a Single BNT162b2 Vaccine Dose

JAMA. 2021 Apr 15;325(18):1898-1899. doi: 10.1001/jama.2021.6042. Online ahead of print.

Authors

Hubert Blain¹, Edouard Tuaillon², Lucie Gamon³, Amandine Pisoni², Stephanie Miot¹, Marie-Christine Picot³, Jean Bousquet⁴

Affiliations

¹ Department of Internal Medicine and Geriatrics, MUSE University, Montpellier, France.
² INSERM U 1058/EFS, University Hospital, Montpellier, France.
³ Clinical Research and Epidemiology Unit, University Hospital, Montpellier, France.
⁴ Department of Dermatology and Allergy, Universitätsmedizin, Berlin, Germany.

Abstract

This study compares IgG antibody levels after a single dose of the BNT162b2 (Pfizer-BioNTech) vaccine in nursing home residents with vs without prior COVID-19.